Literature DB >> 7754235

Characterization of the HBsAg particle lipid membrane.

N Sonveaux1, D Thines, J M Ruysschaert.   

Abstract

HBsAg particles are highly immunogenic and have been shown to be a suitable support for the presentation of foreign epitopes. More information about the topology of the HBsAg protein is a prerequisite to any rational attempt to replace the region of this protein with foreign epitopes without modifying the assembly of the particles. This topology and, more precisely, the mode of interaction of the HBsAg protein with the lipid will depend on the lipid organization in the particle envelope. Nothing is known concerning the lipid organization of HBsAg particles. The only available information concerns their lipid composition. Phospholipase D hydrolysis of HBsAg particles was used here to determine whether the particles were surrounded with a lipid monolayer or bilayer. The lipid fluidity within the particle envelope was evaluated by fluorescence polarization measurements. The data strongly suggest that the HBsAg particle membrane is organized as a discontinuous rigid bilayer of lipids interacting with protein aggregates.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7754235     DOI: 10.1016/0923-2516(96)80588-7

Source DB:  PubMed          Journal:  Res Virol        ISSN: 0923-2516


  3 in total

Review 1.  Avian hepatitis B viruses: molecular and cellular biology, phylogenesis, and host tropism.

Authors:  Anneke Funk; Mouna Mhamdi; Hans Will; Hüseyin Sirma
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

2.  Proposition of a three-dimensional representation of the constitutive protein of the hepatitis B surface antigen particles.

Authors:  N Sonveaux; J M Ruysschaert; R Brasseur
Journal:  J Protein Chem       Date:  1995-08

3.  Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen.

Authors:  Isabelle Desombere; Annick Willems; Yvonne Gijbels; Geert Leroux-Roels
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.